Uptake of antineoplastic agents in pharmacy personnel. Part II: Study of work-related risk factors

International Archives of Occupational and Environmental Health

Volumn 76, Issue 1, 2003, Pages 11-16

  Schreiber, Claudia ^a   Radon, Katja ^a   Pethran, Angelika ^a   Schierl, Rudolf ^a,b   Hauff, Karlheinz ^a   Grimm, Carl Heinz ^a   Boos, Karl Siegfried ^a   Nowak, Dennis ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b Inst/Poliklin Arbeits /Umweltmed   (Germany)

Author keywords

Cytostatic drugs; Internal exposured; Working conditions

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; CYTOSTATIC AGENT; DAUNORUBICIN; DOXORUBICIN; EPIRUBICIN; IDARUBICIN; IFOSFAMIDE; PLATINUM;

ADULT; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DRUG EXPOSURE; DRUG INDUSTRY; DRUG MANUFACTURE; DRUG QUALITY; DRUG URINE LEVEL; FEMALE; GAS CHROMATOGRAPHY; GERMANY; GLOVE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIGH RISK POPULATION; HOSPITAL PHARMACY; HUMAN; LONGITUDINAL STUDY; MALE; MASS SPECTROMETRY; NORMAL HUMAN; OCCUPATIONAL EXPOSURE; OCCUPATIONAL SAFETY; OCCUPATIONAL TOXICOLOGY; PHARMACIST; POTENTIOMETRY; PROTECTION; QUESTIONNAIRE; RISK FACTOR; URINALYSIS; WASTE DISPOSAL; WORK; DRUG FORMULATION; HOSPITAL PERSONNEL; MIDDLE AGED;

ADULT; ANTINEOPLASTIC AGENTS; DRUG COMPOUNDING; FEMALE; HUMANS; JOB DESCRIPTION; MALE; MIDDLE AGED; OCCUPATIONAL EXPOSURE; PERSONNEL, HOSPITAL; PHARMACISTS; PHARMACISTS' AIDES; RISK FACTORS;

EID: 0038282422     PISSN: 03400131     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00420-002-0385-6     Document Type: Article

References (22)

1. Berufsgenossenschaft für Gesundheitsdienst und Wohlfahrtspflege (1998) Sichere Handhabung von Zytostatika. Merkblatt M620
2. Connor TH (1999) Permeability of nitrile rubber, latex, polyurethane and neoprene gloves to 18 antineoplastic drugs. Am J Health Syst Pharm 56:2450-2453
3. Connor TH, Shults M, Fraser M (2000) Determination of the vaporization of solutions of mutagenic antineoplastic agents at 23 and 37 °C using a desiccator technique. Mutat Res 470:85-92
4. Ensslin AS, Huber R, Pethran A, et al. (1997) Biological monitoring of hospital pharmacy personnel occupationally exposed to cytostatic drugs: Urinary excretion and cytogenetics studies. Int Arch Occup Environ Health 70:205-208
5. Falck K, Gröhn P, Sorsa M, et al. (1979) Mutagenicity in urine of nurses handling cytostatic drugs. Lancet 1:1250-1251
6. Hepp R, Gentschew G (1998) Untersuchung zur Aussenkontamination der Primärverpackungen von Zytostatika. Krankenhauspharmazie 1:22-27
7. IARC (1976) Monographs on the evaluation of the carcinogenic risk of chemicals to man. Vol 10 (daunomycin). Lyon, France
8. IARC (1987) Monographs on the evaluation of the carcinogenic risk of chemicals to man. [Suppl 7] (cyclophosphamide). Lyon, France
9. Jardine I, Fenselau C, Appler M, et al. (1978) Quantitation by gas chromatography-chemical ionization mass spectrometry of cyclophosphamide, phosphoramide mustard, and nornitrogen mustard in the plasma and urine of patients receiving cyclophosphamide therapy. Cancer Res 38:408-415
10. Kaijser GP, Underberg WJM, Beijnen JH (1990) The risk of handling cytotoxic drugs. Recommendations for working with cytotoxic drugs. Pharm World Sci 12:228-235
11. Laidlaw JL, Connors TH, Theiss JC, et al. (1984) Permeability of latex and polyvinyl chloride gloves to 20 antineoplastic drugs. Am J Hosp Pharm 41:2618-2623
12. Mader RM, Rizovski B, Steger G, et al. (1991) Permeability of latex membranes to anticancer drugs. Int J Pharm 68:151-156
13. Messerschmidt J, Alt F, Tölg G, et al. (1992) Adsorptive voltammetric procedure for the determination of platinum baseline levels in human body fluids. Fresenius J Anal Chem 343:391-394
14. Mross K, Maessen P, Van Der Vijgh WJF, et al. (1988) Pharmacokinetics and metabolism of epidoxorubicin and doxorubicin in humans. J Clin Oncol 6:517-526
15. Pethran A, Schierl, R, Schmaus, G (2001) Wischproben an Arbeitsplätzen mit Zytostatika-Exposition. Krankenhauspharmazie 1:11-15
16. Pethan A, Schierl R, Hauff K, et al. (2002) Uptake of antineoplastic agents in pharmacy and hospital personnel. Part I: Monitoring of urinary concentrations. Int Arch Occup Environ Health 76: DOI 10.1007/s00420-002-0383-8
17. Schmaus G, Schierl R, Funck S (2002) Monitoring surface contamination by antineoplastic drugs using gas chromatography-mass spectrometry and voltammetry. Am J Health Syst Pharm 59:956-961
18. Sessink PJM, Boer KA, Scheefhals APH, et al. (1992) Occupational exposure to antineoplastic agents at several departments in a hospital. Environmental contamination and excretion of cyclophosphamide and ifosfamide in urine of exposed workers. Int Arch Occup Environ Health 64:105-112
19. Sessink PJM, Cerna M, Rössner P, et al. (1994) Urinary cyclophosphamide excretion and chromosomal aberrations in peripheral blood lymphocytes after occupational exposure to antineoplastic agents. Mutat Res 309:193-199
20. Sessink PJM, Van De Kerkhof MCA, Anzion RBM, et al. (1994) Environmental contamination and assessment of exposure to antineoplastic agents by determination of cyclophosphamide in urine of exposed pharmacy technicians: Is skin absorption an important exposure route? Arch Environ Health 49:165-169
21. Slevin ML, Ang LM, Johnston A, Turner P (1984) The efficiency of protective gloves used in the handling of cytotoxic drugs. Cancer Chemother Pharmacol 12:151-153
22. US Occupational and Health Administration (1986) Work practice guidelines for personnel dealing with cytotoxic (antineoplastic) drugs. OSHA instruction publication 8.1.1. Office of occupational medicine, Department of Labor, Washington, DC, USA